Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)

Torrent Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	11,500	8,351	5,085	3,984	5,726	6,618
Short-Term Investments	850	279	581.6	5.9	264.2	5
Trading Asset Securities	-	1,410	1,561	1,840	1,390	-
Cash & Short-Term Investments	12,350	10,040	7,228	5,830	7,380	6,623
Cash Growth	56.33%	38.91%	23.98%	-21.01%	11.43%	-43.07%
Accounts Receivable	17,830	18,443	19,438	16,325	15,234	16,493
Other Receivables	-	3,390	2,844	2,786	3,618	3,370
Receivables	17,870	21,863	22,300	19,137	18,883	19,900
Inventory	22,710	22,791	22,296	24,623	26,812	21,482
Prepaid Expenses	-	589.5	666.9	514.6	548	526.4
Restricted Cash	-	38.6	48	44.4	45.4	43.5
Other Current Assets	5,860	793	753.3	2,798	1,564	1,234
Total Current Assets	58,790	56,115	53,292	52,947	55,232	49,809
Property, Plant & Equipment	36,290	35,778	34,598	32,469	36,272	35,299
Long-Term Investments	420	332.9	711.1	679.2	681.2	934.7
Goodwill	3,390	3,380	3,375	2,595	3,412	3,421
Other Intangible Assets	43,340	45,828	50,895	35,461	39,855	43,730
Long-Term Deferred Tax Assets	5,810	5,551	5,437	4,937	4,217	4,332
Other Long-Term Assets	2,810	3,596	1,785	1,894	1,056	2,548
Total Assets	150,880	150,606	150,119	130,998	140,747	140,097
Accounts Payable	21,880	20,893	16,788	16,744	20,668	20,488
Accrued Expenses	-	3,784	3,690	3,111	3,324	3,121
Short-Term Debt	-	16,551	18,113	9,620	7,590	11,041
Current Portion of Long-Term Debt	16,340	6,959	10,360	9,718	11,800	14,183
Current Portion of Leases	180	200.6	183.3	147.3	264.7	270.5
Current Income Taxes Payable	910	1,679	313.1	414.8	539.9	351.2
Current Unearned Revenue	-	50	18.3	114.8	109.2	138.5
Other Current Liabilities	9,160	4,134	5,007	4,280	4,621	4,948
Total Current Liabilities	48,470	54,253	54,473	44,151	48,916	54,542
Long-Term Debt	14,140	16,038	24,962	21,232	29,411	32,752
Long-Term Leases	600	644.6	529.3	368.2	222	286.3
Long-Term Unearned Revenue	10	9.6	14.6	19.6	33	54.9
Long-Term Deferred Tax Liabilities	7,930	6,561	4,019	1,936	-	-
Other Long-Term Liabilities	4,690	3,703	3,351	2,865	2,762	3,296
Total Liabilities	75,840	82,044	88,138	71,469	82,375	91,865
Common Stock	1,690	1,692	1,692	846.2	846.2	846.2
Additional Paid-In Capital	-	-	-	43.4	43.4	43.4
Retained Earnings	-	67,908	61,159	57,739	55,905	45,414
Comprehensive Income & Other	73,350	-1,039	-870.5	900.6	1,577	1,928
Total Common Equity	75,040	68,562	61,981	59,530	58,372	48,232
Shareholders' Equity	75,040	68,562	61,981	59,530	58,372	48,232
Total Liabilities & Equity	150,880	150,606	150,119	130,998	140,747	140,097
Total Debt	31,260	40,394	54,148	41,086	49,287	58,533
Net Cash (Debt)	-18,910	-30,354	-46,921	-35,257	-41,907	-51,910
Net Cash Per Share	-55.87	-89.69	-138.64	-104.17	-123.82	-153.38
Filing Date Shares Outstanding	338.82	338.45	338.45	338.45	338.45	338.45
Total Common Shares Outstanding	338.82	338.45	338.45	338.45	338.45	338.45
Working Capital	10,320	1,862	-1,181	8,796	6,316	-4,732
Book Value Per Share	221.48	202.58	183.13	175.89	172.47	142.51
Tangible Book Value	28,310	19,353	7,711	21,474	15,104	1,081
Tangible Book Value Per Share	83.56	57.18	22.78	63.45	44.63	3.19
Land	-	6,804	6,625	6,953	8,210	8,170
Buildings	-	14,910	11,343	11,698	10,149	9,750
Machinery	-	29,168	25,819	25,792	23,298	22,378
Construction In Progress	-	2,808	6,882	5,443	7,439	5,766

Source: S&P Capital IQ. Standard template. Financial Sources.